AzTrials
AzTrials

Substance UseTODOSNCT06276595

Telling Our Daughters Our Story

A study testing Nowhi Isdza bit Nadagoldi: Telling Our Daughters Our Story (TODOS) in people with Substance Use and Sexual Behavior, run by Johns Hopkins Bloomberg School of Public Health at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of this research study is to evaluate a culturally grounded program among American Indian (AI) female children and the children's female caregivers. This project will evaluate the impact of "Nowhi Isdza bit Nadagoldi: Telling Our Daughters Our Story (henceforth referred to as TODOS) on associated risk… Read more about this study

Who is it for?
Ages 8 years and older, women only
Conditions the study is for
Substance Use, Sexual Behavior
What is being tested?
Nowhi Isdza bit Nadagoldi: Telling Our Daughters Our Story (TODOS)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
183 participants
Where
1 siteUnited States
Study dates
30 Mar 2019to 30 Jul 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 years and older
  • Women only
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Female > 18 years of age
  • Self-identify as Apache
  • Be a caregiver of a girl 8-11 years old who is available to enroll in the study
  • Living within 50 miles of the Whiteriver or Fort Apache, Arizona Johns Hopkins program offices
  • Willing to complete all implementation and follow-up assessments
  • Willing to be randomized
Show all 14Show fewer
  • Speaks and reads English
  • Female, 8-11 years old
  • Have a caregiver enrolled in the study
  • Living within 50 miles of the Whiteriver or Fort Apache, Arizona Johns Hopkins program offices
  • Willing to be randomized
  • Willing to complete all implementation and follow-up assessments
  • Speaks and reads English
  • Not cognitively or visually impaired (able to complete questionnaires)

Who cannot join

  • Inability to participate in full intervention or evaluation (e.g., planned move, residential treatment, cognitive impairment, etc.)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • White Mountain Apache Center for Indigenous Health

    Whiteriver, Arizona, 85941

Other trials in United States

About this study

Official title: Telling Our Daughters Our Story: Pre-Conception Health Program for American Indian Girls as They Transition to Adulthood

The objective of this research study is to evaluate a culturally grounded program among American Indian (AI) female children and the children's female caregivers. This project will evaluate the impact of "Nowhi Isdza bit Nadagoldi: Telling Our Daughters Our Story (henceforth referred to as TODOS) on associated risk and protective factors for early substance use and sexual debut through a randomized controlled trial on the White Mountain Apache (WMA) reservation. The investigators will examine whether the TODOS program effectively reduces risk factors and improves protective factors associated with early substance use and sexual debut, with long term goals of reducing teen pregnancy and teen substance use.

Read the detailed description

The investigators will employ a randomized controlled trial (RCT) design to assess the preliminary impact of the TODOS program on many factors, including improving cultural knowledge, family engagement in Apache culture, mother daughter communication, self-esteem, self-efficacy, social support, attitudes about risky behaviors, and knowledge of reproductive health and substance use. Participants will be caregivers of girls ages 8-11 years.

The TODOS program consists of 11 weekly sessions conducted with girls ages 8-11 and the girl's female caregivers. Five of the 11 sessions will be taught to small groups of girls and the girl's mothers, and 6 of the sessions will be taught to individual girl/female caregivers' dyads. The choice to use a mix of group- and home-based sessions is based on findings from the formative phase about preference that certain topics be taught in groups, and certain topics be taught in individual dyads. Each of the sessions (group and individual) will be 60-90 minutes in duration and delivered by a trained Family Health Coach (FHC).

The investigators will enroll up to 94 dyads into four cohorts, each consisting of 18-26 dyads. Dyads will receive either the TODOS program or a control condition. The control condition will consist of 3 group sessions delivered monthly for three months. The investigators will evaluate the TODOS program's feasibility through process data including attendance forms and session summary feedback forms completed by the FHCs. The investigators will assess program acceptability immediately after program completion through implementation assessments completed by caregiver and children participants. The investigators will assess the program's impact on key outcomes immediately after program implementation, 6-month and 12-month post program implementation.

Being tested
Nowhi Isdza bit Nadagoldi: Telling Our Daughters Our Story (TODOS), Control condition - 3 Monthly Group Activities in the Community
Medical subject headings
Substance-Related Disorders, Sexual Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Nowhi Isdza bit Nadagoldi: Telling Our Daughters Our Story (TODOS)Behavioural

    The TODOS program consists of 11 weekly sessions conducted with girls ages 8-11 and their female caregivers. Five of the 11 sessions will be taught to small groups, and 6 of the Each of the sessions (group and individual) will be 60-90 minutes in duration and delivered by a trained Family Health Coach (FHC). Group sessions will take place at a local community center in a private room.

  • Control condition - 3 Monthly Group Activities in the CommunityBehavioural

    The control condition consists of 3 group sessions delivered monthly for three months. The first group session will occur at a community center and will consist of a meal and ice breaker activities. The second group session will consist of going to a movie at the local movie theatre The third group session will consist of going bowling at the local bowling alley.

Study groups in NCT06276595
Study groupRoleWhat they receive
TODOS InterventionExperimentalParticipants in the TODOS Intervention Group will receive the intervention "Nowhi Isdza bit Nadagoldi": Telling Our Daughters Our Story. They will receive 11 intervention sessions of 60-90 minutes over 11 weeks.
Receives: Behavioral: Nowhi Isdza bit Nadagoldi: Telling Our Daughters Our Story (TODOS)
Control condition - 3 Monthly Group Activities in the CommunityOtherChildren and their female caregivers randomized to the control group will receive 3 group sessions delivered monthly for three months. The first group session will occur at a community center and will consist of a meal and ice breaker activities. The second group session will consist of going to a movie at the local movie theatre. The third group session will consist of going bowling at the local bowling alley.
Receives: Behavioral: Control condition - 3 Monthly Group Activities in the Community

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in child cultural knowledge score on knowledge assessment

    Using a questionnaire developed by the study team, investigators will measure change in knowledge from baseline to immediately following the intervention and 6 months and 12 months after program completion via a knowledge assessment completed by the child. This is a 4- question assessment that is on a 5-point Likert scale (score: 0-20) A higher score indicates higher (greater) knowledge.

    Measured: Baseline, 11 weeks, 6 months, 12 months

  2. Change in average score on risky behaviors assessment

    Using a questionnaire developed by the study team, the investigators will assess the impact of the TODOS program on child attitudes related to risky behaviors via a 6-item assessment on a 5-point Likert scale (score: 0-30). Investigators will measure change in knowledge from baseline to immediately following the intervention and 6 months and 12 months after program completion via a knowledge assessment completed by the child. A higher score indicates better attitudes (less endorsement of) risk behaviors.

    Measured: Baseline, 11 weeks, 6 months, 12 months

  3. Change in child reproductive health knowledge via a reproductive health knowledge questionnaire

    Using a questionnaire developed by the study team, investigators will measure change in knowledge from baseline to immediately following the intervention and 6 months and 12 months after program completion via a 3-question knowledge assessment completed by the child (score 0-100). A higher score indicates more knowledge.

    Measured: Baseline, 11 weeks, 6 months, 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Feb 2024
  2. Study start30 Mar 2019
  3. Primary completion22 Mar 2022
  4. Study completion30 Jul 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
183 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06276595
Sponsor's protocol ID
IRB00009466
Acronym
TODOS
Status last verified
Jul 2025
First submitted
16 Feb 2024
Last updated
30 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Nowhi Isdza bit Nadagoldi: Telling Our Daughters Our Story (TODOS) in people with Substance Use and Sexual Behavior, run by Johns Hopkins Bloomberg School of Public Health at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 14 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in child cultural knowledge score on knowledge assessment (time frame: Baseline, 11 weeks, 6 months, 12 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Telling Our Daughters Our Story (NCT06276595) | AzTrials